TSXV:NRX - Post Discussion
Post by
Betteryear2 on Jun 22, 2023 3:19pm
Regeneration & Reinnervation of Spinal Cord in Rats Treated
TORONTO and TEL AVIV, Israel, June 22, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. ("NurExone" or the "Company") (TSXV: NRX) (FSE: J90) (NRX.V), is pleased to report positive imaging results from an internal preclinical study of its investigational drug ExoPTEN. The image analysis and measurements confirmed successful nerve regeneration following traumatic transection of the spinal cord in rats. These imaging results align with previous results showing a remarkable recovery of motor function in 75% of paralyzed rats suffering from spinal cord injuries and treated with the new therapy. Regeneration and Reinnervation of Spinal Cord in Rats (globenewswire.com)
Be the first to comment on this post